PPN Expands Influence in Pharmacy Media with New Hosting Platform and June Podcast Lineup
Pharmacy Podcast Network Unveils New Host Membership & Analytics Platform, Announces Four New Podcast Launches for June
BROWNSVILLE, PA / ACCESS Newswire / May 21, 2025 / The Pharmacy Podcast Network (PPN), the world's largest podcast network dedicated to the profession of pharmacy, proudly announces the launch of a Podcast Hosting Membership and Metrics Platform designed by JB Consulting, a custom healthcare software firm, to empower pharmacy podcast creators with cutting-edge tools, insights, and growth opportunities. This expansion comes alongside the announcement of four new podcasts premiering in June, continuing PPN's mission to elevate authentic and informative healthcare conversations.
Returning by popular demand, the subject of mental health is at the forefront of healthcare. The PPN is excited to announce the new podcast called MindBridge: A Behavioral Health Podcast, hosted by Dr. Ryan Paul Liabenow, PhD, CEO of Mango Health. Focused on mental health and best practices in behavioral-assisted treatments, MindBridge brings critical dialogue to pharmacists and healthcare providers at the forefront of behavioral medicine.
The Executive Dose is another new addition to the Pharmacy Podcast Network, hosted by Stephen Beckman, CEO of YARAL Pharma. This no-fluff, C-suite-level podcast digs into the real-world pressures-and possibilities-reshaping the pharmaceutical industry. Expect sharp insights, straight talk, and stories that hit home for today's pharmacy professionals. 'Pharma, like pharmacy care, is at a tipping point,' said Beckman. 'With 145 million podcast listeners in the U.S., PPN cuts through the noise and delivers what matters to the pharmacy business community. YARAL Pharma is proud to fuel the conversation on this powerful platform.'
The PBM Reform Podcast, originally launched in 2019, returns with new host Greg Reybold, Vice President of Healthcare Policy and General Counsel at American Pharmacy Cooperative, Inc. (APCI). Greg is a veteran healthcare attorney and government affairs professional who has been immersed in PBM reform at the state and federal level for years. His work in the PBM reform arena includes drafting several first-in-the-nation bills which have served as the basis for model legislation throughout the nation.
RxSafe Eyecon is back with a special limited series titled Building Your LTC Pharmacy at Home Business. This critical series explores how independent pharmacies can enter the booming 'LTC-at-Home' market, combatting the rise of pharmacy deserts caused by closures in 2025 and offering a new revenue stream tied to patient access and public health.
'Podcasting has been present in pharmacy because of the PPN,' said Todd Eury, Founder and Editor-in-Chief of the Pharmacy Podcast Network. 'It's a platform built for providers, pharmacy owners, and healthcare insiders since 2009. We're growing with our Host Membership Platform, building new shows, and attracting new talent from pharmacists and thought leaders globally.'
Tonight, PPN will host its 2025 Host Membership Meeting at 7:00 p.m. ET, bringing together over 30 current hosts and welcoming new voices to the network. Special guest John Nosta, internationally recognized AI health philosopher and CEO of NostaLab, will keynote the event.
'The future of healthcare is not just data-driven-it's voice-driven. Podcasting provides the authentic interface where ideas meet innovation,' said John Nosta.
PPN is also launching a new metrics system, enabling hosts and clients to track podcast downloads, episode performance, and listener demographics with more granularity and transparency-empowering better content and business development decisions.
ABOUT PHARMACY PODCAST NETWORK
Founded in 2009, the Pharmacy Podcast Network is the leading podcast media company for the global pharmacy profession, with over 80,000 monthly listeners across 40+ active shows. PPN delivers content focused on business, clinical care, innovation, advocacy, and policy in pharmacy.\
ABOUT YARAL PHARMA
YARAL Pharma, the US generics subsidiary of the multinational pharmaceutical company IBSA, manufactures and markets generic medicines across a range of therapeutic areas including pain and endocrinology. YARAL is committed to improving access to high-quality, authorized and complex generic medications.
ABOUT MANGO HEALTH
Mango Health is a micro-pharmacy platform tailored for behavioral health settings, specializing in psychiatric medication management, medication-assisted treatment (MAT), sexual health, and drug-related infectious disease care.
ABOUT AMERICAN PHARMACY COOPERATIVE, INC. (APCI)
Since 1984, APCI has served independent community pharmacies across the nation with group purchasing, advocacy, and a wide range of industry-leading pharmacy services. The co-op is headquartered in Bessemer, Ala.
About Eyecon | RxSafe
Eyecon | RxSafe is transforming the pharmacy industry through advanced automation technologies that drive efficiency, accuracy, and patient safety. Together, we empower pharmacies with cutting-edge tools that streamline operations, elevate patient care, and ensure long-term success. From visual precision counting to high-volume adherence packaging, our solutions are built to support today's pharmacy challenges and tomorrow's growth. Empowering Pharmacies Through Innovation.
ABOUT NOSTALAB
NostaLab is a health innovation think tank led by John Nosta, a globally recognized thought leader exploring the intersection of digital health, artificial intelligence, and future medicine.
Media Contact:
Todd Eury
CEO
[email protected]
(412) 585-4001
RxPR.net
SOURCE: Pharmacy Podcast Network
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13-06-2025
- Yahoo
From a new asthma detector to using AI responsibly – research at Northumbria University is driving change
Diagnosing lung conditions has traditionally been a difficult – and very expensive – task. Obtaining fluid samples from deep inside organs which are tucked away within our ribcage can't be done without a highly invasive, risky procedure. And most sampling devices can't tell the difference between fluids from the lung and ones from the mouth, often leading to unclear or misleading diagnoses. As a result, millions of patients with common, chronic conditions such as asthma have been left waiting years for effective treatment, while millions of others have been hospitalised with pneumonias impossible to diagnose with current tests. All that is set to change with the launch of a new handheld device later this year, developed by Dr Sterghios A Moschos, a renowned molecular biologist and visiting professor at Northumbria University, which will revolutionise the diagnosis of these diseases. The new breath-sampling technology by PulmoBioMed, a Northumbria University spin-out founded by Moschos in 2020, offers a fast, non-invasive and inexpensive way to test for lung conditions. Called the PBM-Hale, it captures the breath as the patient exhales and separates the droplets that come from the mouth from those found deep in the lung. It has been shown in clinical studies to help quantify lung infections and inflammation in 100% of symptomatic cases. 'PBM-Hale has the potential to transform respiratory care,' says Moschos. 'It is more than 40 times cheaper than endoscopy, where a tube is inserted into the lung, which carries a one-in-seven risk of injury. 'There are seven different types of asthma, and we hope this will allow doctors to quickly diagnose not just the condition but the exact type, without having to try several different kinds of treatment to see if the patient responds.' The device is one of a growing number of pioneering innovations being developed by researchers at Northumbria University to tackle some of the biggest real-world challenges facing us, regionally, nationally and globally. The first to be commercialised, the PBM-Hale is likely to be followed soon by the portable Solar2Water system developed by the university's department of mechanical and construction engineering, which uses solar energy to extract moisture from the air and turn it into water. The unit could be a gamechanger for remote regions where there is no grid connection or water availability nearby. Running on solar energy alone, it can be deployed quickly and easily to any location, such as army camps and field hospitals, or to support displaced communities in refugee camps and disaster zones. Moschos credits much of the success of his innovation to the support he received from the university at every step of the process. 'Since I arrived at Northumbria in 2016 and told them the idea I was working on, I couldn't have asked for more,' he says. 'They gave me everything I needed to create the device, supported the patent and grant applications and helped us apply for programmes to commercialise academic research.' PulmoBioMed raised an extraordinary £1.4m in an investment round last year to help grow its business, as well as a £700,000 grant from Innovate UK. It's these kinds of groundbreaking advances that have powered Northumbria's meteoric rise through the ranks for research: in the most recent Research Excellence Framework (REF2021), Northumbria made the biggest leap of any UK university in research power, climbing from 50th in 2014 to 23rd in 2021. It was the second time Northumbria achieved this impressive feat, after previously rising from 80th place in 2008. Building on this momentum, and with a mission to create new knowledge that shapes change, Northumbria is investing in, and attracting funding for, new research innovations that will have an impact on society and the economy. One of its most ambitious projects to date is the North East Space Skills and Technology centre (NESST). A state-of-the-art facility being developed by the university, NESST is the result of a £50m investment with partners including the UK Space Agency and Lockheed Martin UK Space that will create new knowledge and skills intended to transform the UK's space economy. 'We doubled the value of our research awards in the last year,' says Prof Louise Bracken, Northumbria's pro vice-chancellor for research and knowledge exchange. 'Not only does that money fund more research, it also demonstrates the value of that research to others.' The university's social mobility ethos – approximately 40% of its undergraduates are from lower socioeconomic backgrounds, and 65% are from the north-east region – also underpins many of its research projects. Overcoming social inequities is central to all the research done by another of its biggest schemes, the Centre for Health and Social Equity (CHASE). 'We're working with people experiencing homelessness, vulnerable adults, children and young people and veterans, to drive policy to better serve their needs. We want to ensure our research has tangible benefits for society and the environment. That's our USP at Northumbria,' says Bracken. The principle of benefiting society is also at the heart of the work being done by professor of law Marion Oswald, who leads a flagship research project. The multimillion-pound PROBabLE Futures project, in collaboration with several other universities as well as partners from law enforcement and commercial tech, explores how AI can be adopted responsibly in law enforcement and the criminal justice system. The 'probable' in PROBabLE Futures refers to the fact that AI produces results which are probabilities, but not certainties. This means that great care needs to be taken when using AI in the criminal justice system to avoid unfairness and miscarriages of justice. 'We're looking at how these AI systems are being used in policing, potentially becoming part of criminal justice – in the US, they're even being used to help determine sentences – and then in prisons and with probation,' she says. 'We're also thinking about whether this sector should have new independent oversight.' The team's AI checklist for policing has recently been adopted by the National Police Chiefs' Council – an instance of the university's research making a significant impact in the real world. It is this type of outward facing research that has inspired the university's brand-new Northumbria Centre for Responsible AI. 'As AI becomes widespread, we're pulling together all the research, experience and expertise at the university to look at how we make sure it's being used for the public good,' says Oswald. 'It's one of the biggest issues of our time, so it's really exciting.' Many applications of AI are relatively mundane, but others will have far-reaching consequences for people's lives, 'like deciding whether somebody should get a government benefit or not, or deciding whether somebody should be put on a police watchlist', she says. 'We're concerned that the public sector thinks very carefully about how it implements this technology and that people should have the skills and knowledge to navigate this new AI-informed world.' Find out more about how Northumbria University is shaping futures and driving change
Yahoo
13-06-2025
- Yahoo
Louisiana attorney general investigates CVS over mass texts about pharmacy bill
LOUISIANA () — This week, CVS customers across Louisiana were met with an alarming text message: 'Last-minute legislation in Louisiana threatens to close your CVS Pharmacy—your medication cost may go up and your pharmacist may lose their job. Contact your elected officials to protect your access.' The text, which quickly triggered confusion and concern, refers to House Bill 358—a late-session proposal that would ban pharmacy benefit managers (PBMs) like CVS Caremark from owning or controlling pharmacies in the state. Critics of the message say it's more than a warning; it's a political campaign that may have crossed a legal line. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now 'People give their information to health care providers to provide patient information for the betterment of their health,' said former state senator and pharmacist Fred Mills. 'I don't know if they give this information for political purposes.' PBMs act as a middleman between insurance companies, drug manufacturers and pharmacies. Supporters of the bill argue that this dual role (particularly when companies like CVS own both the PBM and the pharmacy) creates a conflict of interest and limits consumer choice. 'If you work for a company that decides you'll pay $5 or $10 for your prescriptions, the PBM implements that plan,' Mills said. 'So, they're kind of like a Visa Card for prescriptions.' But Louisiana Attorney General Liz Murrill says CVS went too far by using private customer data for lobbying. Federal investigation underway into allegedly undocumented LCG workers 'They were sending out information using people's personal cell phone numbers to lobby against legislation that they didn't like,' Murrill said. 'That is not the purpose for which they obtained our personal information.' In response, Murrill says her office has issued a cease-and-desist letter and opened an investigation into whether CVS violated the state's Unfair Trade Practices Act. 'CVS has cornered the market and used that market to run a lot of independent pharmacists out of business,' she said. 'It's also running up our costs of medication.' In a public statement, CVS claimed the legislation would force the company to close 119 pharmacies in Louisiana, impacting one million patients and nearly 2,700 employees. But Murrill and other state officials argue the company's messaging is misleading. 'The loss of independent pharmacies has been much more damaging to us than losing a large chain pharmacy like CVS,' Murrill said. 'It is so damaging to our rural communities. And they have been decidedly persistent in putting them out of business.' The bill did not pass despite pressure from Governor Landry. If Governor Landry does call a special session, it would most likely happen in August. Louisiana attorney general investigates CVS over mass texts about pharmacy bill Rubio: US 'not involved' in Israel's strike inside Iran Teacher accused of giving Denver middle school students cannabis brownies Israel attacks Iran's capital with explosions booming across Tehran 'It was still chasing her': 9-year-old girl attacked by shark while swimming at Florida beach Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
13-06-2025
- Yahoo
Louisiana lawmakers push for transparency in drug pricing, bill advances
BATON ROUGE, La. (Louisiana First) — A bill aimed at regulating pharmacy benefit managers (PBMs) has passed and is awaiting the governor's signature. HB 264, authored by Michael Echols (R-La.), is geared towards ensuring fair reimbursement and transparency in drug pricing. The bill redefines the term rebate, which would include a wide range of discounts received by PBMs. These changes are meant to highlight how PBMs negotiate and profit from deals with drug manufacturers. It would also allow PBMs to label certain submitted information as confidential. The Commissioner of Insurance would have the authority to review PBM records and compensation structures and ensure reasonable reimbursements. Donald Trump Jr. took to social media, asking Louisiana to pass HB 358, which would allow a pharmacy technician to work remotely in certain circumstances. 'It's time to pass HB358 and end the charade that costs hard-working Americans so much money when buying prescription drugs. Enough is Enough!' Trump wrote. EBR Metro Council picks new advisor for Raising Canes River Center redevelopment project 'It's a big problem in Baton Rouge': Authorities suspect human trafficking in massage parlors College Drive flyover project complete, brings relief to Baton Rouge drivers Louisiana lawmakers push for transparency in drug pricing, bill advances Judge blocks Trump's National Guard deployment in Los Angeles Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
